Pierre Louis helps stop the bleeding
French physician changed the face of clinical practice.
In his 2004 book The Great Influenza, an epic account of the 1918-20 pandemic that has been called “the deadliest in ...
How COVID-19 can affect our sense of smell
Study finds key enzyme in only one area of the nose.
US researchers think they have discovered why people with coronavirus sometimes lose their sense of smell, even when ...
Malaria discovery could have broader impact
Researchers testing potential to treat other diseases.
New research into malaria suggests targeting enzymes from the human host rather than the pathogen itself could offer ...
Multifocal lenses may slow myopia
Researchers try a new approach on young children.
Multifocal contact lenses usually worn by people over 40 could slow the progression of myopia in children as young as...
Study assesses Victoria’s COVID-19 response
Reproduction ratio down and thousands of infections 'averted’.
COVID-19 control measures in the Australian state of Victoria reduced the reproduction ratio of the virus from 1.75 t...
More on the language of immunity
Peter Doherty explains some other perplexing terms.
This continues the process from last week (the I essay) of introducing terms that will be encountered as we engage wi...
Cancer team finetunes its approach
New technology keeps an eye on the instruments.
An Australian research group has developed a technology it says can reliably analyse the proteins in cancer samples o...
Tests for Alzheimer’s disease show promise
Blood biomarkers could make detection cheaper and easier.
In converging studies, four teams of scientists say they are getting closer to developing blood tests that could dete...
The ‘I’ language of immunology
Peter Doherty continues his analysis of COVID-19 issues.
Some of the early essays in this series were about immunity, but not much has been said so far about how the immune s...
Genomic fingerprints meet coronavirus
What is it, how does it work, and how can it help?
By Rebecca Rockett, University of Sydney. If you had told me in January that “genomics” would become a buzzword in...
COVID-19: The lessons learned to date
Peter Doherty concludes his analysis of the first months.
Part 3 of 3. Read Part 1 and Part 2. Back in 2012 I was invited to do a short Q&A book on pandemics for an Oxford...
Cosmos Q&A: Quest for a vaccine
How an Australian team progressed to human trials.
Researchers at the University of Queensland this week began the first human trials of their COVID-19 vaccine. You can...